| Cancer | Prevalence-duration | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Two-year | Five-year | Ten-year | |||||||
| Both sexes | Males | Females | Both sexes | Males | Females | Both sexes | Males | Females | |
| All cancers | 661.2 | 678.8 | 644.0 | 1,372.0 | 1,388.9 | 1,355.5 | 2,161.6 | 2,128.1 | 2,194.5 |
| Oral cavity and pharynx | 16.0 | 22.0 | 10.2 | 33.3 | 45.0 | 21.8 | 53.5 | 72.4 | 34.9 |
| Esophagus | 3.8 | 5.7 | 1.9 | 5.5 | 8.3 | 2.8 | 7.0 | 10.3 | 3.8 |
| Stomach | 9.0 | 12.0 | 6.0 | 14.9 | 19.2 | 10.7 | 21.4 | 26.5 | 16.3 |
| Colorectal | 90.7 | 99.3 | 82.3 | 185.9 | 202.1 | 170.0 | 285.9 | 306.0 | 266.3 |
| Colon excluding rectum | 59.9 | 61.2 | 58.7 | 123.1 | 124.7 | 121.6 | 191.1 | 191.2 | 191.0 |
| Rectum and rectosigmoid | 31.4 | 39.0 | 24.1 | 64.3 | 79.4 | 49.4 | 97.4 | 118.0 | 77.2 |
| Anus | 2.7 | 2.4 | 3.0 | 5.4 | 4.6 | 6.2 | 8.3 | 7.0 | 9.6 |
| Liver | 2.9 | 4.5 | 1.4 | 4.8 | 7.4 | 2.3 | 6.1 | 9.2 | 3.0 |
| Pancreas | 5.7 | 5.5 | 5.8 | 7.6 | 7.5 | 7.7 | 9.4 | 9.2 | 9.7 |
| Larynx | 5.8 | 9.6 | 2.1 | 12.2 | 20.2 | 4.3 | 20.8 | 34.4 | 7.5 |
| Lung and bronchus | 54.5 | 57.4 | 51.7 | 85.5 | 88.2 | 82.8 | 114.7 | 118.8 | 110.7 |
| Soft tissue | 4.5 | 5.0 | 4.0 | 9.3 | 10.3 | 8.3 | 15.2 | 16.5 | 14.0 |
| Skin melanoma | 23.9 | 25.5 | 22.4 | 54.0 | 56.0 | 52.2 | 91.4 | 91.6 | 91.3 |
| Breast | 115.3 | 1.9 | 226.5 | 266.6 | 3.7 | 524.6 | 456.0 | 5.9 | 897.8 |
| Cervix uteri | … | … | 14.4 | … | … | 33.4 | … | … | 61.6 |
| Corpus uteri | … | … | 42.4 | … | … | 94.7 | … | … | 163.0 |
| Ovary | … | … | 20.2 | … | … | 38.6 | … | … | 57.6 |
| Prostate | … | 236.0 | … | … | 539.7 | … | … | 848.1 | … |
| Testis | … | 9.8 | … | … | 23.9 | … | … | 44.4 | … |
| Bladder (including in situ) | 32.7 | 49.9 | 15.9 | 68.0 | 103.2 | 33.5 | 111.3 | 167.1 | 56.5 |
| Kidney and renal pelvis | 18.8 | 22.7 | 14.9 | 39.8 | 48.0 | 31.8 | 63.7 | 76.3 | 51.3 |
| Brain | 6.6 | 7.7 | 5.5 | 11.9 | 13.7 | 10.3 | 18.7 | 21.1 | 16.4 |
| Thyroid | 18.5 | 7.6 | 29.2 | 40.4 | 17.5 | 62.8 | 63.3 | 27.6 | 98.4 |
| Hodgkin lymphoma | 5.0 | 5.5 | 4.5 | 11.7 | 13.1 | 10.3 | 21.5 | 23.9 | 19.1 |
| Non-Hodgkin lymphoma | 28.8 | 31.0 | 26.6 | 59.1 | 62.9 | 55.3 | 92.1 | 96.2 | 88.1 |
| Multiple myeloma | 7.9 | 8.6 | 7.2 | 14.2 | 15.2 | 13.2 | 18.4 | 19.6 | 17.1 |
| Leukemias | 18.0 | 21.5 | 14.6 | 35.8 | 42.2 | 29.5 | 55.0 | 63.9 | 46.3 |
| Other, unknown | 40.3 | 41.2 | 39.4 | 75.8 | 76.3 | 75.2 | 115.5 | 114.8 | 116.1 |
| Note: Prevalence proportions were determined by a person-based analysis. Source: Canadian Cancer Registry, Statistics Canada and Provincial/Territorial Cancer Registries. Table source: Statistics Canada, 2009, " Cancer prevalence in the Canadian population", Health Reports, Vol. 20, No. 1, catalogue number 82-003-X. |
|||||||||